Tracking Your Health: What the Data Technology Really Means
Emma Blake
It's been an incredible journey over the past year, and what better way to commemorate this milestone than by delving into the exciting world of stock market investing? Whether you're a recent graduate, a young professional, or someone simply looking to diversify their financial portfolio, understanding the basics of investing in the stock market is a crucial step towards building long-term wealth.
At ALTHEON, we believe in the incredible power of AI to change how you manage your health.
At ALTHEON, we believe in theincredible power of AI to change how you manage your health. Anew study, backed by experts including Microsoft AI, showsjust how powerful this approach is, proving that advanced AIcan help understand health issues with incredible accuracy, oftenmore precisely than traditional methods, and even help save on costs.This research provides a clear look at the future of proactive healthinsights – a future ALTHEON is bringing to you right now.
The paper introduces a new way totest AI, called the Sequential Diagnosis Benchmark(SDBench). Instead of giving AI all the answers at once,SDBench makes AI think like a doctor in real life. Itasks the AI to gather information step-by-step, askingquestions and ordering tests, just like a doctor would. Every stephas a 'cost' attached, making sure the AI learns to be smartand efficient, not just accurate.
For ALTHEON, thesefindings are incredibly significant. They validate our core beliefthat by seamlessly integrating your diverse health data –from every wearable and doctor's record – and applying advanced,intelligently orchestrated AI, we can provide you withunparalleled, proactive health insights. Just as MAI-DxO helpsAI "think iteratively and act judiciously" inclinical diagnosis, ALTHEON's platform empowers you tounderstand your unique health patterns, make informed decisions, andproactively manage your well-being with precision andcost-effectiveness. This research reinforces our commitment tobringing you the future of personalized, AI-driven health.
The results are truly compelling.When paired with a leading language model (like OpenAI's GPT-3),MAI-DxO achieved 80% diagnostic accuracy, a staggeringfour times higher than the 20% average of generalist physiciansevaluated on the same challenging cases from the New England Journalof Medicine. Furthermore, MAI-DxO reduced diagnostic costsby 20% compared to physicians, and an impressive 70% compared tooff-the-shelf AI models without this advanced orchestration.When optimized for maximum accuracy, MAI-DxO reached anastounding 85.5% accuracy.
What's more, the MAI-DxOapproach proved to be model-agnostic, meaning its benefitsweren't limited to one AI model. It consistently boosted thediagnostic accuracy of various leading language models (includingthose from Google, Anthropic, and Meta) by an average of 11percentage points, demonstrating the power of structured reasoning toenhance even the most advanced AI. This robustness, even oncases published after the AI models' training cut-off dates,highlights its ability to generalize and avoid memorization.
For ALTHEON, thesefindings are incredibly significant. They validate our core beliefthat by seamlessly integrating your diverse health data –from every wearable and doctor's record – and applying advanced,intelligently orchestrated AI, we can provide you withunparalleled, proactive health insights. Just as MAI-DxO helpsAI "think iteratively and act judiciously" inclinical diagnosis, ALTHEON's platform empowers you tounderstand your unique health patterns, make informed decisions, andproactively manage your well-being with precision andcost-effectiveness. This research reinforces our commitment tobringing you the future of personalized, AI-driven health.
